Jonathan Ho talked to Dallas Business Journal about why software firm Tyler Technologies is outpacing the market and investors are lining up.

Equity Research
Jonathan Ho talked to Dallas Business Journal about why software firm Tyler Technologies is outpacing the market and investors are lining up.
Stay up-to-date with the latest William Blair news and insights
William Blair initiated research coverage of Contineum Therapeutics, Inc. (CTNM $3.93), a clinical-stage biotech developing small-molecule therapeutics for high-unmet-need indications in the prevalent neuroinflammation and immunology space.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures